NanoRepro AG Cash Flow Conversion Efficiency
NanoRepro AG cash flow conversion efficiency. Based on the latest financial reports, NanoRepro AG (NN6) has a cash flow conversion efficiency ratio of 0.055x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.05 Million ≈ $2.40 Million USD) by net assets (€37.30 Million ≈ $43.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of NanoRepro AG (2013–2024)
Cash flow conversion efficiency of NanoRepro AG from 2013 to 2024. This chart illustrates how NanoRepro AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NanoRepro AG stock quote for real-time trading data and today's change.
NanoRepro AG Cash Flow Conversion Ratio Explained
NanoRepro AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
NanoRepro AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NanoRepro AG ranked by their cash flow conversion efficiency. Also see NanoRepro AG market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mepet Metro Petrol ve Tesisleri Sanayi Ticaret AS
IS:MEPET
|
-0.032x |
|
Prestige Wealth Inc.
NASDAQ:AURE
|
-0.001x |
|
Diversified Gateway Solutions Bhd
KLSE:0131
|
-0.015x |
|
Key Tronic Corporation
NASDAQ:KTCC
|
-0.039x |
|
LITHIUMBANK RESOURCES
F:HT9
|
-0.608x |
|
Plutus Financial Group Limited Ordinary Shares
NASDAQ:PLUT
|
-0.019x |
|
Rackla Metals Inc
V:RAK
|
-0.294x |
|
M4B SA ZY 8
F:24D
|
N/A |
Annual Cash Flow Conversion Efficiency for NanoRepro AG (2013–2024)
The table below shows the annual cash flow conversion efficiency of NanoRepro AG from 2013 to 2024. Review NanoRepro AG (NN6) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €38.14 Million ≈ $44.59 Million |
€9.86 Million ≈ $11.53 Million |
0.259x | +201.70% |
| 2023-12-31 | €40.38 Million ≈ $47.20 Million |
€-10.26 Million ≈ $-12.00 Million |
-0.254x | -191.73% |
| 2022-12-31 | €47.43 Million ≈ $55.45 Million |
€13.14 Million ≈ $15.37 Million |
0.277x | +95.60% |
| 2021-12-31 | €57.61 Million ≈ $67.35 Million |
€8.16 Million ≈ $9.54 Million |
0.142x | +200.82% |
| 2020-12-31 | €7.99 Million ≈ $9.34 Million |
€-1.12 Million ≈ $-1.31 Million |
-0.141x | -1.63% |
| 2019-12-31 | €4.43 Million ≈ $5.18 Million |
€-612.40K ≈ $-715.96K |
-0.138x | -201.53% |
| 2018-12-31 | €5.62 Million ≈ $6.57 Million |
€-257.60K ≈ $-301.16K |
-0.046x | +84.68% |
| 2017-12-31 | €3.82 Million ≈ $4.47 Million |
€-1.14 Million ≈ $-1.34 Million |
-0.299x | -18.04% |
| 2016-12-31 | €3.03 Million ≈ $3.55 Million |
€-769.70K ≈ $-899.86K |
-0.254x | +38.28% |
| 2015-12-31 | €2.27 Million ≈ $2.66 Million |
€-934.60K ≈ $-1.09 Million |
-0.411x | -43.01% |
| 2014-12-31 | €1.91 Million ≈ $2.23 Million |
€-548.00K ≈ $-640.67K |
-0.287x | +39.65% |
| 2013-12-31 | €1.64 Million ≈ $1.92 Million |
€-783.00K ≈ $-915.41K |
-0.476x | -- |
About NanoRepro AG
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. It offers rapid diagnostic tests, such as family planning, and preve… Read more